Literature DB >> 8788445

(-)-Pentazocine analgesia in mice: interactions with a sigma receptor system.

C C Chien1, G W Pasternak.   

Abstract

(-)-Pentazocine is active in the tailflick assay in CD-1 mice, although it shows a biphasic dose-response curve with a peak effect of only 30%. Co-administration of haloperidol shifts the dose-response curve to the left and elevates the maximal response to 70% through a blockade of sigma 1 receptors, but the curve remains biphasic. (+)-Pentazocine is inactive in all antinociceptive assays, either alone or with haloperidol. The analgesic actions of (-)-pentazocine are readily reversed by nor-binaltorphimine, but not by the mu-selective opioid receptor antagonist beta-funaltrexamine, implying a kappa 1-opioid receptor mechanism of action. This conclusion is supported by the ability of antisense oligodeoxynucleotides directed against the KOR-1 clone, which encodes the kappa 1-opioid receptor, to block (-)-pentazocine analgesia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788445     DOI: 10.1016/0014-2999(95)00552-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  (+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord.

Authors:  Leon F Tseng; Quinn H Hogan; Hsiang-En Wu
Journal:  Life Sci       Date:  2011-10-02       Impact factor: 5.037

3.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

4.  Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Authors:  Adam L Halberstadt; James Hyun; Michael A Ruderman; Susan B Powell
Journal:  Pharmacol Biochem Behav       Date:  2016-05-26       Impact factor: 3.533

5.  Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.

Authors:  M A King; S Bradshaw; A H Chang; J E Pintar; G W Pasternak
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Sigma binding in a human neuroblastoma cell line.

Authors:  J Ryan-Moro; C C Chien; K M Standifer; G W Pasternak
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

8.  Ligand directed signaling differences between rodent and human κ-opioid receptors.

Authors:  Selena S Schattauer; Mayumi Miyatake; Haripriya Shankar; Chad Zietz; Jamie R Levin; Lee-Yuan Liu-Chen; Vsevolod V Gurevich; Mark J Rieder; Charles Chavkin
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

9.  (-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice.

Authors:  Soichiro Ide; Masabumi Minami; George R Uhl; Masamichi Satoh; Ichiro Sora; Kazutaka Ikeda
Journal:  Mol Pain       Date:  2011-04-10       Impact factor: 3.395

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.